A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis - Related Studies

Home

A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis

This study has been completed.

Study NCT00034476. Last updated on July 18, 2006. Information provided by Eli Lilly and Company

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Sepsis

2	More general conditions related to this trial
		Infection
		Inflammation
		Pathologic Processes
		Systemic Inflammatory Response Syndrome

3	Interventions listed in this trial
		sPLA2 Inhibitor

4	Sponsors listed in this trial
		Eli Lilly and Company